Online citations, reference lists, and bibliographies.

Early Diagnosis Of Rheumatoid Arthritis: An Introduction To The Newly Designed Iran Criteria For Rheumatoid Arthritis

Iraj Salehi, Shabnam Khazaeli, Mohammad Khak
Published 2011 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
More than 14 years of clinical practice in rheumatology led the author to discover the prognostic role of anti-citrullinated protein antibody (ACPA) as well as the erosions found by MRI, in detecting the RA patients resulting in establishing a new set of criteria by revising the 1987 ACR classification—Iran Criteria for Rheumatoid Arthritis. Medical records of 243 patients at the outpatient Rheumatology Clinic of the author (private sector) were reviewed for the data on the criteria of the 1987 ACR, 2010 ACR/European League against Rheumatism (EULAR), and Iran Criteria for RA. In addition to modifying the 1987 ACR classification, Iran Criteria for RA adds some additional information to the ACR criteria (including ACPA and bony erosions detected by MRI), and any patient who satisfies 6 out of 12 points is considered as a definite RA patient. Sensitivity of the three classifications was calculated considering the clinical diagnosis by a single rheumatologist as the gold standard. A total of 63 male and 180 female patients with a mean follow-up duration of 28.24 ± 50.19 months were considered. Mean age at diagnosis and mean disease duration were 49.16 ± 15.38 years and 7.04 ± 6.87 months, respectively. The sensitivity for Iran Criteria for RA, 1987 ACR classification, and 2010 ACR/EULAR criteria were calculated as 98.4, 59.7, and 66.3%, respectively. Comparing Iran Criteria for RA with ACR and ACR/EULAR criteria, it was concluded that our newly introduced criteria is a more sensitive instrument in determining RA patients in the early stages of the disease.
This paper references
33 : 45 – 50 criteria for rheumatoid arthritis : slight improvement over the 1987 ACR criteria
V Majithia (2007)
10.1080/08916930410001708733
Autoantibodies to Citrullinated (Poly)Peptides: A Key Diagnostic and Prognostic Marker for Rheumatoid Arthritis
Albert J W Zendman (2004)
10.1016/s0084-3873(08)79116-8
Meta-analysis: Diagnostic Accuracy of Anti–Cyclic Citrullinated Peptide Antibody and Rheumatoid Factor for Rheumatoid Arthritis
Donald L. Kimpel (2008)
BeneWt of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis
VP Nell (2004)
10.1002/art.1780310302
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.
F. C. Arnett (1988)
10.1002/art.23439
Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies.
J K de Vries-Bouwstra (2008)
10.1016/j.jaad.2004.07.023
Rheumatoid arthritis: a review of the cutaneous manifestations.
Anousheh Sayah (2005)
10.1093/oxfordjournals.epirev.a036058
Epidemiology of rheumatoid arthritis: update.
Marc C. Hochberg (1990)
10.1016/j.sder.2007.02.007
Rheumatoid nodule.
Vicente García-Patos (2007)
Anti-cyclic citrullinated peptide revised criteria for the classiWcation of rheumatoid arthritis
KP Liao (2008)
10.1093/rheumatology/33.8.765
The Roche Rheumatology Prize Lecture. The optimal management of early rheumatoid disease: the key to preventing disability.
Paul Emery (1994)
Validation of the 2010 ACR/EULAR classiWcation
K Britsemmer (2011)
10.1016/j.amjmed.2007.04.005
Rheumatoid arthritis: diagnosis and management.
Vikas Majithia (2007)
10.1093/rheumatology/kel418
Classification criteria for rheumatoid arthritis--time to abandon rheumatoid factor?
Deborah P M Symmons (2007)
10.1002/1529-0131(200111)44:11<2485::AID-ART428>3.0.CO;2-S
Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later.
Alain Saraux (2001)
10.1136/ard.2010.138461
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
Daniel Aletaha (2010)
10.1136/ard.2010.148619
Validation of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: slight improvement over the 1987 ACR criteria
Karin Britsemmer (2011)
SigniWcance of anti-CCP antibodies in modiWcation of 1987 ACR classiWcation criteria in diagnosis of rheumatoid arthritis
J Zhao (2010)
10.1007/s00296-008-0570-3
The association of anti-CCP antibodies with disease activity in rheumatoid arthritis
Münevver Serdaroğlu (2008)
10.1002/art.27580
The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report.
Tuhina Neogi (2010)
10.7326/0003-4819-152-7-201004060-00010
Systematic Review: Accuracy of Anti–Citrullinated Peptide Antibodies for Diagnosing Rheumatoid Arthritis
Penny Whiting (2010)
10.1093/rheumatology/ken332
The use of MRI in early RA.
Fiona Marion Florence McQueen (2008)
Anticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis.
W J van Venrooij (2002)
10.1136/ard.2003.019992
Prognostic laboratory markers of joint damage in rheumatoid arthritis.
Elisabet Lindqvist (2005)
10.1136/ard.2005.044354
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).
Bernard Combe (2007)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar